Delphyr, an Amsterdam-based AI platform integrating into electronic health records (EHRs), has raised €1.75 million ($2M) in seed funding from investors including Innovatiefonds Noord-Holland and founders of Hugging Face and DEGIRO. The platform offers instant patient data search, summarization, evidence-based guidance, workflow automation, and ambient listening for clinicians in primary care and hospitals. The capital will develop and expand these AI agents to reduce administrative burdens while ensuring EU data privacy.
Health AI Funding Surges Early 2026
Delphyr's raise aligns with heating investor interest: Ease Health emerged from stealth with $41M Series A on March 2, 2026, while ambient scribe Abridge has secured $300M+. Earlier, Truveta raised $515M for data platforms. Delphyr targets Dutch EHRs like Bricks, differentiating via seamless integration and European data sovereignty amid EU AI Act compliance.
Clinicians Spend 40% on Admin Tasks
Healthcare professionals lose up to 40% of their time to administrative work and information searches. In the Netherlands, ICU bed functionality dropped from 1,050 to 850 amid staffing shortages. Current EHRs fragment data across systems, slowing decisions and fueling burnout. Legacy tools fail to deliver real-time summaries or automate notes without exporting data outside Europe.
Sovereign AI Embeds in Dutch EHRs
Delphyr processes all data on secure European infrastructure, integrating zero-disruption into systems like Bricks (Tetra) and ChipSoft without new screens or data export. Its M1 model, a 7B-parameter Dutch clinical LLM, outperforms LLaMA3 on medical benchmarks like PubMedQA (76.8%). Features include ambient listening for notes and cited evidence-based guidance, projecting €66k annual savings for a 3-GP practice.
Citations Build Clinician Trust
Unlike US-focused scribes, Delphyr emphasizes verifiable outputs with citations, clinician control, and GDPR/ISO compliance. Live in Bricks for primary care since January 2026, it automates summaries, letters, and e-consults. Pilots with Erasmus MC ICU and Dutch Endometriosis Clinic validate hospital use.
Regional Fund Backs Privacy Focus
Innovatiefonds Noord-Holland, a Noord-Holland province-backed VC, provided a prior €275k convertible and joined this round, signaling conviction in local MedTech. Investments from Hugging Face co-founder Thomas Wolf add AI expertise. This mix of regional mission capital and tech angels positions Delphyr for EU scaling.
AI Healthcare Market Scales to Trillions
The global AI in healthcare market stands at $56B in 2026, projected to reach $1,033B by 2034 at 44% CAGR. Competitors like Nabla lead ambient scribes in the US, where 66% of Epic hospitals adopt such tools. EU trends favor privacy-compliant integrations as AI Act enforcement nears August 2026.
Anesthesiologist Targets Admin Crisis
Founder and CEO Michel Abdel Malek, an MD anesthesiologist and PhD candidate in generative AI for anesthesia at Leiden UMC, draws from clinical experience. His peer reviews for BMJ Digital Health and British Journal of Anaesthesia, plus World Summit AI speaking, underscore domain credibility. No prior exits, but rapid traction includes STZ Innovation Challenge win.
As Michel Abdel Malek, Founder & CEO noted:
"Healthcare professionals often spend a significant portion of their time on administrative work and searching for information. From my experience as an anesthesiologist, I know how frustrating that can be. With this investment, we can further develop and expand our AI agents so professionals get time back from day one, while maintaining the highest standards of privacy, security, and clinical quality."
Integrations Scale Across Dutch Care
Post-raise, Delphyr expands Bricks rollout in primary care and hospital pilots via partners like InterSystems. Active hiring for AI engineers, sales, and product roles supports national growth. STZ award positions it for broader Dutch hospital adoption.